Low-dose abiraterone acetate for the treatment of prostate cancer: An observational cohort study
{{output}}
Objective: To compare radiographic progression-free survival in metastatic prostate cancer patients treated with low-dose abiraterone versus standard-dose abiraterone acetate (Abi-SD), and to evaluate prostate-specific antigen pr... ...
